| NDC Code | 43742-1507-1 |
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-1507-1) |
| Product NDC | 43742-1507 |
| Product Type Name | HUMAN OTC DRUG |
| Proprietary Name | Female Stimulant |
| Non-Proprietary Name | Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (suis), Kreosotum, Oophorinum (suis), Uterus (suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (suis), Hypophysis Suis, Aconiticum Acidum Cis-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (alkaligenes), Mutabile Bacillus (bach) |
| Dosage Form | LIQUID |
| Usage | ORAL |
| Start Marketing Date | 20190820 |
| End Marketing Date | 20300102 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Manufacturer | Deseret Biologicals, Inc. |
| Substance Name | LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; GOLDENSEAL; PETROSELINUM CRISPUM WHOLE; AQUILEGIA VULGARIS; SUS SCROFA UMBILICAL CORD; SUS SCROFA ADRENAL GLAND; PORK HEART; WOOD CREOSOTE; SUS SCROFA OVARY; SUS SCROFA UTERUS; ESTRONE; SUS SCROFA PITUITARY GLAND; ACONITIC ACID, (Z)-; LACHESIS MUTA VENOM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; SEPIA OFFICINALIS JUICE; SUS SCROFA PINEAL GLAND; APIS MELLIFERA VENOM; ESTRADIOL; PROGESTERONE; TESTOSTERONE; SUS SCROFA PLACENTA; ALCALIGENES FAECALIS; ESCHERICHIA COLI |
| Strength | 10; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 12; 6; 8; 30; 13; 8; 8; 16; 10; 6; 8; 8; 30; 8 |
| Strength Unit | [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
| Pharmacy Classes | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| DEA Schedule | CIII |